EP1082111A4 - Testsystem zur identifizierung von verbindungen die die melaninherstellung fördern und dadurch identifizierte retinoidähnliche verbindungen - Google Patents

Testsystem zur identifizierung von verbindungen die die melaninherstellung fördern und dadurch identifizierte retinoidähnliche verbindungen

Info

Publication number
EP1082111A4
EP1082111A4 EP99921689A EP99921689A EP1082111A4 EP 1082111 A4 EP1082111 A4 EP 1082111A4 EP 99921689 A EP99921689 A EP 99921689A EP 99921689 A EP99921689 A EP 99921689A EP 1082111 A4 EP1082111 A4 EP 1082111A4
Authority
EP
European Patent Office
Prior art keywords
assay
compounds
retinoid
identification
melanin production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921689A
Other languages
English (en)
French (fr)
Other versions
EP1082111A1 (de
Inventor
Deepa Rungta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of EP1082111A1 publication Critical patent/EP1082111A1/de
Publication of EP1082111A4 publication Critical patent/EP1082111A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP99921689A 1998-05-06 1999-05-06 Testsystem zur identifizierung von verbindungen die die melaninherstellung fördern und dadurch identifizierte retinoidähnliche verbindungen Withdrawn EP1082111A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8447898P 1998-05-06 1998-05-06
US84478P 1998-05-06
PCT/US1999/009845 WO1999056740A1 (en) 1998-05-06 1999-05-06 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay

Publications (2)

Publication Number Publication Date
EP1082111A1 EP1082111A1 (de) 2001-03-14
EP1082111A4 true EP1082111A4 (de) 2004-03-10

Family

ID=22185213

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921689A Withdrawn EP1082111A4 (de) 1998-05-06 1999-05-06 Testsystem zur identifizierung von verbindungen die die melaninherstellung fördern und dadurch identifizierte retinoidähnliche verbindungen

Country Status (13)

Country Link
EP (1) EP1082111A4 (de)
JP (1) JP3669925B2 (de)
KR (1) KR100538417B1 (de)
CN (1) CN1247192C (de)
AR (1) AR018340A1 (de)
AU (1) AU762364B2 (de)
BR (1) BR9909599A (de)
CA (1) CA2324001C (de)
ID (1) ID26632A (de)
IL (1) IL138772A0 (de)
NO (1) NO20004723L (de)
WO (1) WO1999056740A1 (de)
ZA (1) ZA200005026B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19926779A1 (de) * 1999-06-11 2000-12-14 Basf Ag Verwendung von substituierten Vinyl-tetrahydronaphthalinen und Vinyl-benzotetrahydropyranen als Lichtschutzmittel
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
FR2831439A1 (fr) * 2002-02-14 2003-05-02 Oreal Composition comprenant au moins un autobronzant et au moins un compose activteur de la melanogenese
JP4303616B2 (ja) * 2004-03-01 2009-07-29 花王株式会社 メラノソーム転送の検出法
KR100798853B1 (ko) * 2005-02-15 2008-01-28 (주)한국스티펠 레티노이드를 유효성분으로 하는 백반증 예방 및 치료용 약학적 조성물
CA2662218A1 (en) * 2006-08-29 2008-03-06 Reinnervate Limited Retinoid compounds and their use
US9162984B2 (en) 2007-03-30 2015-10-20 University Of Rochester Small-molecule modulators of melanin expression
AU2012308582B2 (en) 2011-09-15 2016-11-24 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Therapeutic compounds
US10328040B2 (en) 2014-01-17 2019-06-25 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic methods
SG10202102348YA (en) * 2016-09-08 2021-04-29 Agency Science Tech & Res Use of polyamines in compositions and methods for inducing or promoting skin darkening and regulating melanogenesis
US10238626B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US10231947B2 (en) 2017-01-23 2019-03-19 Arizona Board Of Regents On Behalf Of Arizona State University Isochroman compounds and methods of use thereof
US10238655B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Dihydroindene and tetrahydronaphthalene compounds
CA3082262A1 (en) 2017-11-14 2019-05-23 Unilever Plc Peptides for increasing melanin in melanocytes
US11419803B2 (en) 2017-12-06 2022-08-23 Conopco, Inc. Skin darkening composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021146A1 (en) * 1992-04-22 1993-10-28 Ligand Pharmaceuticals Incorporated Compounds having selectivity for retinoid x receptors
WO1994017796A1 (en) * 1993-02-11 1994-08-18 Allergan, Inc. Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors
EP0749752A1 (de) * 1995-06-19 1996-12-27 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Verwendung von spezifische RXR-Rezeptorligande
WO1997000892A2 (en) * 1995-06-23 1997-01-09 The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services Depigmenting activity of agouti signal protein and peptides thereof
WO1997033881A1 (fr) * 1996-03-14 1997-09-18 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Composés bicycliques-aromatiques
WO1997035998A1 (en) * 1996-03-28 1997-10-02 Trustees Of Boston University Methods of modulating melanin synthesis
WO1998022423A1 (fr) * 1996-11-19 1998-05-28 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5824685A (en) * 1995-02-01 1998-10-20 The Johns Hopkins University School Of Medicine Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
FR2735370B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes agonistes des recepteurs rxrs

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021146A1 (en) * 1992-04-22 1993-10-28 Ligand Pharmaceuticals Incorporated Compounds having selectivity for retinoid x receptors
WO1994017796A1 (en) * 1993-02-11 1994-08-18 Allergan, Inc. Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors
EP0749752A1 (de) * 1995-06-19 1996-12-27 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Verwendung von spezifische RXR-Rezeptorligande
WO1997000892A2 (en) * 1995-06-23 1997-01-09 The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services Depigmenting activity of agouti signal protein and peptides thereof
WO1997033881A1 (fr) * 1996-03-14 1997-09-18 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Composés bicycliques-aromatiques
WO1997035998A1 (en) * 1996-03-28 1997-10-02 Trustees Of Boston University Methods of modulating melanin synthesis
WO1998022423A1 (fr) * 1996-11-19 1998-05-28 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEARD R L ET AL: "SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF STILBENE RETINOIDANALOGS SUBSTITUTED WITH HETEROAROMATIC CARBOXYLIC ACIDS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 38, no. 15, 21 July 1995 (1995-07-21), pages 2820 - 2829, XP000575926, ISSN: 0022-2623 *
BOEHM M F ET AL: "SYNTHESIS AND STRUCTURE - ACTIVITY RELATIONSHIPS OF NOVEL RETINOID X RECEPTOR-SELECTIVE RETINOIDS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 37, no. 18, 2 September 1994 (1994-09-02), pages 2930 - 2941, XP000615432, ISSN: 0022-2623 *
See also references of WO9956740A1 *

Also Published As

Publication number Publication date
AU3882999A (en) 1999-11-23
IL138772A0 (en) 2001-10-31
CA2324001A1 (en) 1999-11-11
KR100538417B1 (ko) 2005-12-22
CN1247192C (zh) 2006-03-29
BR9909599A (pt) 2001-09-25
NO20004723D0 (no) 2000-09-21
ZA200005026B (en) 2001-05-22
CA2324001C (en) 2007-08-07
AU762364B2 (en) 2003-06-26
CN1299274A (zh) 2001-06-13
JP3669925B2 (ja) 2005-07-13
AR018340A1 (es) 2001-11-14
ID26632A (id) 2001-01-25
JP2002513756A (ja) 2002-05-14
EP1082111A1 (de) 2001-03-14
KR20010043147A (ko) 2001-05-25
WO1999056740A1 (en) 1999-11-11
NO20004723L (no) 2000-11-06

Similar Documents

Publication Publication Date Title
IL138772A0 (en) Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
AU7612900A (en) Identification of alleles
AU4080099A (en) The synthesis of an economic web and the identification of new market niches
PT1140824E (pt) Metodo para producao de 3-alcanoilindolos e 3-alquilindolos
NO993827D0 (no) Identifikasjon av transpondere
GB9904804D0 (en) Identification of bacteria
GB9800855D0 (en) Production of alumina
NO982824L (no) Produktsjonsbroennradar
GB9824444D0 (en) Micro-Organism identification
GB9805417D0 (en) Production of microparticles
AU3098099A (en) Biological modification of vaso-occlusive devices
ZA987666B (en) Manufacture of thermoset products
GB9802927D0 (en) Remote interrogation of monitored locations
GB9802487D0 (en) Production of heptafluoropane
TW405345U (en) Improvement of identification necklace structure
DK199800993A (da) Identifikationsarmbånd
AU2002240837A1 (en) Identification of lead structures
DE69934809D1 (de) Kennzeichen von Tonkanälen
GB9916432D0 (en) Identification of computers
EP1043397A4 (de) Identifikation der neuen substraters i-traf der ikki-i kinase
GB9800881D0 (en) Production of patterned paper
TW360428U (en) Structure for fastener of hanging tag
GB9822713D0 (en) Automated identification of microtubes
UA25274A (uk) Устаhовка для очищеhhя виробhичих стоків
PL330001A1 (en) Method of making commodity identification tags

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/68 B

Ipc: 7G 01N 33/50 B

Ipc: 7A 61K 31/44 B

Ipc: 7A 61K 31/19 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040120

17Q First examination report despatched

Effective date: 20040723

17Q First examination report despatched

Effective date: 20040723

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090725